ASCO 2016 melanoma highlights: immunotherapy developments and further data on checkpoint inhibitors
Adipocytes in the tumor microenvironment: an emerging target for melanoma treatment
Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Keep up to date with all the latest news with our monthly newsletter